Pharmatest has provided assistance for almost a hundred pharmaceutical, biotechnology and nutraceutical companies worldwide in their efficacy research. Most of our customers come to us before their candidates enter official pipelines and therefore wish to remain undisclosed. Therefore, we do not disclose any of our customers unless they specifically agree.

Below you can find some testimonials of our customers who have been satisfied with the quality of our services.

Selected customer testimonials

Dr. Karl ZiegelbauerSVP Therapeutic Research Groups, Pharmaceuticals Division, Bayer Pharma AG, Germany
Read More
"Bayer has worked for several years with Pharmatest and we are very impressed about the high quality of the work they have done for us."
Dr. Dana T. AftabExecutive Vice President, Business Operations, Exelixis Inc., USA
Read More
"Exelixis has been working with Pharmatest since 2011, and we have been very pleased with their excellent data quality, detailed and thorough reports, and highly professional and knowledgeable staff.”
Dr. Leslie HolsingerVice President of Biology, Virobay Inc., USA
Read More
"Virobay has worked with Pharmatest on both in vitro and in vivo model analysis of drug candidates and we are very pleased with the excellent quality of their work and the high level of scientific expertise they provide to our studies.”
Dr. Pekka KallioHead of Oncology Research, Orion Oyj, Finland
Read More
“Orion started to use services of Pharmatest more than 10 years ago, and we are happy about the excellent scientific quality of their work and reporting.”
Dr. Nick FlinnHead of Pre-clinical Development, Amura Therapeutics, England
Read More
"Amura has worked closely with Pharmatest for over a decade in the areas of bone turnover and bone metastases. Pharmatest has provided support and advice in addition to a first class in vitro and in vivo screening service for the analysis and progression of Amura's drug candidates. We are always impressed with the excellent quality of their work and the high level of scientific expertise they provide to our studies.”
Dr. Hubert ChenChief Medical Officer, Pfenex Inc., USA
Read More
“It was a great pleasure working with Pharmatest. The scientific expertise and advice offered by the Pharmatest team were top notch. There was excellent, proactive communication from the very beginning of the project, which finished on time and within budget. I have no hesitations in recommending Pharmatest as a high-quality CRO for preclinical services in skeletal diseases.”
Dr. Satu VainikkaCEO, Valirx Plc, UK
Read More
"Pharmatest has been our preferred supplier of preclinical proof-of-concept studies for some time now and we are very satisfied about the high quality and scientific expertise that they provide."
Hanne Heidenheim BakM.Sc. Pharm, Senior Project Director, Head of Project Management, Zealand Pharma A/S, Denmark
Read More
"It has been a pleasure working with the Pharmatest team. You have been an excellent communicator, always informing us promptly on changes or questions that have come up and providing great feedback to our questions. We certainly experience Pharmatest as a very competent company with very professional employees."
Dr. Jean-Baptiste MarchandHead of Proteins Science Group, Transgene, France
Read More
”Transgene and Pharmatest have successfully collaborated since 2009 for the in vitro and in vivo preclinical evaluation of TG’s monoclonal platform in different skeletal diseases. Transgene was particularly impressed by the high professionalism of Pharmatest’s scientist staff, who participated actively nearby our teams in the designs, execution and analysis of the experiments.”